Physician profile
Smit Singla
NPI 1851445829
$11,030.69
in general payments reported to CMS, 2019-2025
10 companies · $2,310 in 2025
The $2,310 reported for 2025 was more than what 83% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,481 · 2021: $2,791 · 2022: $149 · 2023: $16.55 · 2024: $3,283 · 2025: $2,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,874 · Education: $1,000 · Food and Beverage: $467 · Consulting Fee: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,873.87 |
| Education | $1,000.00 |
| Food and Beverage | $467.35 |
| Consulting Fee | $268.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,028.78 | 2019-2025 | |
| Medical Device Business Services, INC. | $2,179.70 | 2019 | |
| Ethicon US, LLC | $271.27 | 2019-2024 | Stratafix |
| Astrazeneca Pharmaceuticals LP | $268.50 | 2025 | Imfinzi |
| Polynovo North America LLC | $71.10 | 2022 | |
| Molli Surgical (US) INC | $62.22 | 2024 | |
| Angiodynamics, INC. | $45.78 | 2022-2023 | Nanoknife |
| Coopersurgical, INC. | $38.83 | 2025 | Insorb |
| Boston Scientific Corporation | $36.74 | 2021 | |
| Integra Lifesciences Corporation | $27.77 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smit Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.